de Boer Daniel Anton
Chief Executive Officer
de Boer Daniel Anton has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Aug 3, 2026.
On the most recent filing, de Boer Daniel Anton is listed as Chief Executive Officer at ProQR Therapeutics N.V. Inside the rolling window, de Boer Daniel Anton reported 3 open-market purchases totaling $853K in PRQR and no open-market sales. The largest disclosed transaction in the window is a purchase of 200,000 PRQR shares on Jul 31, 2026, worth $354K.
Companies traded
Other insiders at PRQR
Insider Buying
$853K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has de Boer Daniel Anton made?
de Boer Daniel Anton has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.
Which companies does de Boer Daniel Anton trade?
de Boer Daniel Anton has filed SEC Form 4 disclosures for 1 company, including PRQR.
When was de Boer Daniel Anton's most recent SEC Form 4 filing?
de Boer Daniel Anton's most recent SEC Form 4 filing on Tracefour is dated Aug 3, 2026.
What is de Boer Daniel Anton's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, de Boer Daniel Anton is listed as Chief Executive Officer.
What is de Boer Daniel Anton's total buy and sell value in the current window?
Inside the rolling retention window, de Boer Daniel Anton bought $853K and sold $0 based on SEC Form 4 filings.
What was de Boer Daniel Anton's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 200,000 PRQR shares on 2026-07-31, worth $354K, per SEC Form 4 filings.